Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer.
Saved in:
| Title: | Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer. |
|---|---|
| Authors: | Herzog SK; Integrative Molecular and Biomedical Sciences Program, Baylor College of Medicine, Houston, Texas.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Stevens JH; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Gu G; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Grimm SL; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Cardoza K; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Hawkins AGM; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Cancer and Cell Biology Program, Baylor College of Medicine, Houston, Texas., Lin H; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Ramos D; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Beyer AR; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Edwards DG; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Dustin D; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas., Yang HJ; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Liang N; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas., Khan AF; Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, Texas., Bawa-Khalfe T; Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, Texas., McGrail DJ; Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio., Lin SY; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Coarfa C; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Fuqua SAW; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas. |
| Source: | Cancer research [Cancer Res] 2026 Apr 02; Vol. 86 (7), pp. 1707-1723. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41499130 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Herzog+SK%22">Herzog SK</searchLink>; Integrative Molecular and Biomedical Sciences Program, Baylor College of Medicine, Houston, Texas.; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Stevens+JH%22">Stevens JH</searchLink>; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Gu+G%22">Gu G</searchLink>; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Grimm+SL%22">Grimm SL</searchLink>; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Cardoza+K%22">Cardoza K</searchLink>; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Hawkins+AGM%22">Hawkins AGM</searchLink>; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Cancer and Cell Biology Program, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Lin+H%22">Lin H</searchLink>; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Ramos+D%22">Ramos D</searchLink>; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Beyer+AR%22">Beyer AR</searchLink>; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Edwards+DG%22">Edwards DG</searchLink>; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Dustin+D%22">Dustin D</searchLink>; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Yang+HJ%22">Yang HJ</searchLink>; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Liang+N%22">Liang N</searchLink>; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Khan+AF%22">Khan AF</searchLink>; Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Bawa-Khalfe+T%22">Bawa-Khalfe T</searchLink>; Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22McGrail+DJ%22">McGrail DJ</searchLink>; Department of Inflammation and Immunity, Cleveland Clinic, Cleveland, Ohio.<br /><searchLink fieldCode="AU" term="%22Lin+SY%22">Lin SY</searchLink>; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Coarfa+C%22">Coarfa C</searchLink>; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Fuqua+SAW%22">Fuqua SAW</searchLink>; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222984705R%22">Cancer research</searchLink> [Cancer Res] 2026 Apr 02; Vol. 86 (7), pp. 1707-1723. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>2984705R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-7445 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200085472%22">00085472 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41499130 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/0008-5472.CAN-24-3891 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1707 Titles: – TitleFull: Defective DNA Damage Response Is a Targetable Therapeutic Vulnerability in ESR1-Mutant Breast Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Herzog SK – PersonEntity: Name: NameFull: Stevens JH – PersonEntity: Name: NameFull: Gu G – PersonEntity: Name: NameFull: Grimm SL – PersonEntity: Name: NameFull: Cardoza K – PersonEntity: Name: NameFull: Hawkins AGM – PersonEntity: Name: NameFull: Lin H – PersonEntity: Name: NameFull: Ramos D – PersonEntity: Name: NameFull: Beyer AR – PersonEntity: Name: NameFull: Edwards DG – PersonEntity: Name: NameFull: Dustin D – PersonEntity: Name: NameFull: Yang HJ – PersonEntity: Name: NameFull: Liang N – PersonEntity: Name: NameFull: Khan AF – PersonEntity: Name: NameFull: Bawa-Khalfe T – PersonEntity: Name: NameFull: McGrail DJ – PersonEntity: Name: NameFull: Lin SY – PersonEntity: Name: NameFull: Coarfa C – PersonEntity: Name: NameFull: Fuqua SAW IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 04 Text: 2026 Apr 02 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1538-7445 Numbering: – Type: volume Value: 86 – Type: issue Value: 7 Titles: – TitleFull: Cancer research Type: main |
| ResultId | 1 |